Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 23, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - April 23, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 218     Next >>     Go To Page:

3/24/17 - FDA Approves Symproic (naldemedine) Once-Daily Tablets C-II for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain
OSAKA, Japan& FLORHAM PARK, N.J.& STAMFORD, Conn. Shionogi Inc. and Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration approved Symproic 0.2 mg tablets C-II as a once-daily oral peripherally-acting mu-opioid receptor antagonist medication for the treatment of opioid-induced constipation in adult patients with chron
3/24/17 - OMNI HEALTH, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Unless otherwise indicated, references in this Quarterly Report on Form 10- Q to "we," "us," and "our" are to the Company, unless the context requires otherwise. The following discussion and analysis by our management of our financial condition and results of operations should be read in conjunction with our unaudited condensed interim financial st
3/24/17 - Over-the-Counter (OTC) Drugs and Dietary Supplements Markets 2016-2021: Global Markets Report 2017
The Over-the-Counter Drugs and Dietary Supplements: Global Markets Report Includes:- An overview of the global markets for OTC drugs and dietary supplements- Analyses of global market trends, with data from 2015, 2016, and projections of CAGRs through 2021- Information about how pharmacies affect the OTC drug market- Analysis of new developments th
3/24/17 - VANC Pharmaceuticals Provides Marketing Update
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets provides marketing update as part of its ongoing program to bring value added products to the Canadian pharmacy industry. "I am pleased to announce that VANC's premium natural iron supplement Hema-Fer? has been accepted by two ph
3/23/17 - BioPharmX Reports Fourth Quarter and Full Year 2017 Financial Results
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, today reported financial results for the quarter and year ended Jan. 31, 2017, and will provide an update on the company's clinical development efforts and highlights from the year. "We are pleased to report that last year was a very product
3/23/17 - How the U.S. Keeps Herbal Dietary Supplements Safe
The overall safety and efficacy of supplements sold in the U.S. is ensured through a strong and complex framework of federal regulations, industry-adopted best practices, and the inherent safety of ingredients used in supplement. Supplement companies are also required to register manufacturing facilities with the FDA and FDA regularly inspects...
3/23/17 - Pharmaceutical industry grows by 7.5 percent to $5b [Syrian Arab News Agency]
Medical research firm IMS Health data shows the value of the medical market increased by 7.49 percent to $5 billion in 2016 thanks to robust growth of unbranded generic medicine. The market for unbranded medicine grew by 18 percent, the highest among other types, said Jorge Wagner, chairman of International Pharmaceutical Manufacturers Group, durin
3/23/17 - PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Entry into a Material Definitive Agreement
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Entry into a Material Definitive Agreement Item1.01. Entry into a Material Definitive Agreement. On March 19, 2017, Provectus Biopharmaceuticals, Inc. (the Company) entered into an exclusive Definitive Financing Commitment Term Sheet with a group of the Companys stockholders (the PRH Gr
3/22/17 - Innovus Pharmaceuticals Announces the Cash Redemption of All Outstanding Convertible Notes
Innovus Pharmaceuticals, Inc., today announced the cash redemption of all remaining outstanding convertible notes. Headquartered in San Diego, Innovus Pharma is an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription...
3/22/17 - Inside the regulated world of influencer marketing for Big Pharma
Not all influencer campaigns are created equal. A weight-loss supplement company, embroiled in legal battles over product recalls, recently reached out to influencer marketer Brett Sosnik hoping to help restore its image. Such a lengthy process is typical for influencer marketing in the weight loss supplement space where influencers must discuss th
3/22/17 - IntriCon Backs Bipartisan Legislation to Make Hearing Aids Available Over the Counter
IntriCon Corporation, a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced its support of legislation to make hearing aids available for those with mild to moderate hearing loss available over the counter. The Over-the-Counter Hearing Aid Act of 2017 was introduced on March 21
3/22/17 - Pharmaceutical Packaging Market Expected Value Up to 94.93 Billion USD by 2021
The pharmaceutical packaging market is projected to reach USD 94.93 Billion by 2021, at a CAGR of 6.4% from 2016 to 2021. The growth of the pharmaceutical packaging market is driven by increasing demand for drug delivery devices and blister packaging, rising demand for improved healthcare services due to growing urbanization in emerging economies,
3/21/17 - Avoid Over-the-Counter Medication Overdosing
We have all experienced standing in the isle at the store staring at the over-the-counter medications. According to the FDA, "For a medicine to work for you-and not against you-you've got to take the right dose." Here are 10 tips from the FDA:.
3/21/17 - FDA APPROVES XADAGO (SAFINAMIDE) FOR PARKINSONS DISEASE (PD) PATIENTS
Milan, Italy and Morristown, NJ, U.S.A.,- March 21, 2017- Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system and pain, and its partners Zambon S.p.A. and US WorldMeds, LLC, announced today that the Food and Drug Administration has approved
3/21/17 - Grassley, Colleagues Reintroduce Legislation to Make More Hearing Aids Available Over the Counter
Washington, D.C. U.S. Senators Elizabeth Warren, Chuck Grassley, Maggie Hassan, and Johnny Isakson, today reintroduced legislation to make hearing aids for those with mild to moderate hearing loss available over the counter. A companion bill led by Representatives Joe Kennedy III and Marsha Blackburn was also introduced in the House. In addition,
3/21/17 - HEALTHWAREHOUSE.COM, INC. - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operation.
The following discussion of results of operations and financial condition is based upon, and should be read in conjunction with, our consolidated financial statements and accompanying notes thereto, included elsewhere in this Annual Report. TABLE OF CONTENTS Overview HealthWarehouse.com, Inc. is an online mail order pharmacy, licensed and/or author
3/21/17 - Members of Congress Introduce Bipartisan Legislation to Make Hearing Aids Available Over the Counter
Washington, D.C.- U.S. Senators Elizabeth Warren, Chuck Grassley, Maggie Hassan, and Johnny Isakson, today reintroduced legislation to make hearing aids for those with mild to moderate hearing loss available over the counter. A companion bill led by Representatives Joe Kennedy III and Marsha Blackburn was also introduced in the House. In addition,
3/21/17 - North America Dietary Supplements Market to Cross $38 Billion by 2022: TechSci Research Report
NEW YORK, March 21, 2017/ PRNewswire-iReach/ According to TechSci Research report, " North America Dietary Supplements Market By Product Type, By End User, By Point of Sale, Competition Forecast& Opportunities, 2012-2022", the region's dietary supplements market is forecast to surpass$ 38 billion by 2022, on the back of increasing awareness among
3/21/17 - Over-the-Counter Hearing Aid Act of 2017 Introduced in Congress
The Over-the-Counter Hearing Aid Act of 2017 was introduced Monday, March 20. The reintroduced legislation is designed to make hearing aids for those with mild-to-moderate hearing loss available over the counter (OTC), and require the FDA to write regulations ensuring the new OTC category meets the same high standards for safety, consumer labeling,
3/21/17 - Sen. Grassley, Colleagues Reintroduce Legislation to Make Hearing Aids Available
U.S. Senators Elizabeth Warren, Chuck Grassley, Maggie Hassan, and Johnny Isakson, today reintroduced legislation to make hearing aids for those with mild to moderate hearing loss available over the counter. A companion bill led by Representatives Joe Kennedy III and Marsha Blackburn was also introduced in the House. In addition, the proposed legis
3/20/17 - Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod
Valeant Pharmaceuticals International, Inc.' s wholly owned subsidiary, Bausch+ Lomb, and Nicox S.A. today announced that the U.S. Food and Drug Administration has set a PDUFA date of August 24, 2017 for its decision on the New Drug Application for latanoprostene bunod ophthalmic solution, 0.024%. "If granted, the FDA's approval of latanoprosten
3/20/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 12457) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Nonprescription Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss safety issues associated with over-the-counter analgesic combination products used for upset stomach and hangover indications under the...
3/20/17 - PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Regulation FD Disclosure
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Regulation FD Disclosure Item7.01. Regulation FD Disclosure. On March20, 2017, Provectus Biopharmaceuticals, Inc. (the Company) issued a press release (the Press Release) announcing that it entered into an exclusive Definitive Financing Commitment Term Sheet with a group of the Companys
3/20/17 - Wearable, lifestyle-friendly medical device represents a uniquely powerful and safe option for managing aches and pain.
By a News Reporter-Staff News Editor at Pain& Central Nervous System Week Quadrabloc?, a wearable device for the management of pain and discomfort associated with activity and aging, is now available for chronic pain sufferers and weekend warriors. With the commercial release of Quadrabloc by Gradient Medical Inc., consumers have an effective a
3/17/17 - Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed Products
Acura Pharmaceuticals, Inc. and MainPointe Pharmaceuticals, LLC today announced that they have entered into a License Agreement to have MainPointe exclusively market NEXAFED and NEXAFED Sinus in the US and Canada. MainPointe is an emerging OTC pharmaceutical company that brings added leverage to our NEXAFED business, commented Bob Jones, Ac
Articles(s): 1 - 25 of 218     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415